OTB-658

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOTB-658
Drug Alias NameOTB-658
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-Resistant +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Xiehe No 2 Pharmaceutical FactoryInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Xiehe No 2 Pharmaceutical FactoryInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-Resistant +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A